메뉴 건너뛰기




Volumn 8, Issue 8, 2008, Pages 767-775

Which treatment for nonalcoholic fatty liver disease?

Author keywords

Diabetes; Lipid peroxidation; Metformin; Orlistat; Statins; Weight loss

Indexed keywords

ALPHA TOCOPHEROL; ANTILIPEMIC AGENT; ANTIOXIDANT; ASCORBIC ACID; ATORVASTATIN; BETAINE; CASPASE INHIBITOR; CLOFIBRATE; GEMFIBROZIL; GLITAZONE DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOSARTAN; METFORMIN; NATEGLINIDE; OMEGA 3 FATTY ACID; PENTOXIFYLLINE; PIOGLITAZONE; PLACEBO; PRAVASTATIN; PREBIOTIC AGENT; PROBIOTIC AGENT; PROBUCOL; RIMONABANT; ROSIGLITAZONE; S ADENOSYLMETHIONINE; SIBUTRAMINE; TETRAHYDROLIPSTATIN; TROGLITAZONE; UNINDEXED DRUG; URSODEOXYCHOLIC ACID;

EID: 50049106453     PISSN: 13895575     EISSN: None     Source Type: Journal    
DOI: 10.2174/138955708784912193     Document Type: Article
Times cited : (9)

References (100)
  • 99
    • 0032162184 scopus 로고    scopus 로고
    • National Institutes of Health
    • National Institutes of Health Obes. Res., 1998, 6 (Suppl 2), 51S.
    • (1998) Obes. Res , vol.6 , Issue.SUPPL. 2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.